TrialBlood2010

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.

Christiane Pott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.